Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoral Products Regulatory News (CRU)

Share Price Information for Coral Products (CRU)

Share Price is delayed by 15 minutes
Get Live Data
5.625    0.00 (0.00%)
Bid:
5.50
Ask:
5.75
Spread: 0.25 (4.545%)
Market Cap: £5.00m
CRU Live PriceLast checked at - London Stock Exchange

Intraday Coral Products Share Chart

Acquisition and Placing

30 Nov 2012 07:00

RNS Number : 3800S
Coral Products PLC
30 November 2012
Β 

ο»Ώ

Coral Products plc

("Coral" or "the Company")

Β 

Acquisition & Placing

Β 

Acquisition of Freehold

Β 

Coral Products plc (AIM: CRU), which specialises in the design, manufacture and supply of injection-moulded plastic products, is pleased to report that it has exchanged contracts in relation to its acquisition ("Acquisition") of the freehold of its manufacturing premises at Haydock for an aggregate cash consideration of Β£1.75 million ("Consideration"). The Acquisition is expected to complete on or before 7 December 2012.

Β 

The Consideration is equivalent to the valuation of the premises and is to be satisfied as to Β£1.4 million of new loan facilities provided by the Company's bankers and Β£350,000 from an issue of new ordinary shares, as detailed below.

Β 

The new loan facilities, which are subject to financial covenants being met, comprise (i) a 10 year loan of Β£1.225 million at an interest rate of 2.95 per cent. above base and (ii) a five month loan of Β£175,000 at an interest rate of 3.35 per cent. above base. The 10 year loan is subject to a repayment holiday of five months.

Β 

The Acquisition is expected to result in net annual cost savings of approximately Β£250,000, taking account of saved rental payments and additional interest payments due on the new loan facilities.

Β 

Β 

Placing

Β 

Subject to various conditions precedent being met including the provision of bank finance, in mid-October the Company agreed the terms of a subscription agreement to issue 3,800,000 new ordinary shares of 1 penny each (the "Placing Shares") at the then mid-market price of 12.5 pence per share (the "Placing Price") to funds managed by MAM Funds plc, to raise Β£475,000 (before expenses). The funds raised will be used as part-consideration for the Acquisition and for general working capital purposes. The issue of the Placing Shares is conditional on completion of the Acquisition.

Β 

The Placing Shares, which will rank pari passu with the existing ordinary shares, will represent 9.06 per cent. of Coral's enlarged issued share capital. The Placing Price represents a discount of 33.8 per cent. to the closing mid-market price per Coral ordinary share of 18.875 pence as at 29 November 2012, being the last business day prior to this announcement.

Β 

Application for admission to trading on AIM of the Placing Shares will be made upon completion of the Acquisition and admission of the Placing Shares is expected to occur shortly thereafter. A further announcement will be made in due course.

Β 

Following the issue of the Placing Shares, the issued share capital of the Company will comprise 41,935,609 ordinary shares of 1 penny each.

Β 

Β 

Chairman Joe Grimmond commented:

Β 

"In early October we were offered the very attractive opportunity to purchase the freehold of the premises occupied by Coral at Haydock. It has been funded 70 per cent. by bank debt with the balance through an equity placing of 3.8 million shares agreed in mid- October with funds managed by MAM Funds plc at the then prevailing market price. This acquisition allows Coral to develop with confidence a centre of excellence on its own site of 100,000 square feet.

Β 

"The purchase will save Β£304,000 p.a. in rent and will be earnings enhancing. This is another step in rebuilding the profitability and asset base of the group."

Β 

Β 

Β 

Β 

Enquiries

Β 

Coral Products plc

Joe Grimmond, Non-Executive Chairman

Warren Ferster, Chief Executive & Managing Director

Β 

Β 

Tel: 07703 518 148

Tel: 01942 272 882

Nominated Adviser

Cairn Financial Advisers LLP

Tony Rawlinson

Avi Robinson

Β 

Β 

Tel: 020 7148 7900

Broker

XCAP Securities plc

David Lawman / Adrian Kirk

Β 

Β 

Tel: 020 7101 7070

Β 

Bankside Consultants

Richard Pearson

Tel: 020 7367 8888

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCUKOWRUNAAUAA
Date   Source Headline
20th Apr 20264:15 pmRNSDirector/PDMR Shareholding
20th Apr 202612:20 pmRNSTrading Update
16th Feb 20267:00 amRNSAcquisition of the assets of AAC Cyroma Limited
8th Jan 20267:00 amRNSHalf-year Financial Report
26th Nov 20254:45 pmRNSResult of AGM & Directorate Change
26th Nov 20257:00 amRNSAGM Statement
31st Oct 202512:00 pmRNSNotice of AGM and Posting of Annual Report
31st Oct 20257:00 amRNSFinal Results
28th Aug 20253:50 pmRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
10th Jul 20258:58 amRNSDirectorate Change
8th Jul 202510:08 amRNSIssue of Options
7th Jul 202510:08 amRNSFull Year Trading Update and Acquisition Update
30th May 20257:00 amRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSDirectorate Change
4th Apr 20253:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20252:15 pmRNSDirector/PDMR Shareholding
1st Apr 20253:50 pmRNSAcquisition of the assets of Arrow Film Converters
20th Mar 202511:00 amRNSIce Cream & Food Container three-year Agreement
4th Mar 20257:00 amRNSRenewal of Contract
27th Feb 202512:57 pmRNSDirector/PDMR Shareholding
26th Feb 202511:07 amRNSDirector/PDMR Shareholding
21st Feb 202511:02 amRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSCompletion of Property Sale and Directorate Change
3rd Feb 20257:00 amRNSChange of Adviser
28th Jan 20254:35 pmRNSDirector/PDMR Shareholding
27th Jan 20257:00 amRNSHalf-year Report
7th Jan 20257:00 amRNSProperty Sales and Insurance Claim Settlement
4th Dec 20247:00 amRNSDirectorate Change
12th Nov 20247:00 amRNSDirectorate Change
25th Oct 20247:00 amRNSDirectorate Change
23rd Oct 20244:30 pmRNSResult of General Meeting
14th Oct 20247:00 amRNSTrading Statement
17th Sep 20247:00 amRNSFinal Results
24th Jul 20247:00 amRNSSale and Leaseback of Runcorn Factory Site
11th Jun 20247:00 amRNSTrading Statement
23rd May 20245:45 pmRNSTransaction in Own Shares
23rd May 20247:00 amRNSDirector/PDMR Shareholding
22nd May 20246:20 pmRNSTransaction in Own Shares
13th May 20244:30 pmRNSDirector/PDMR Shareholding
9th May 20242:50 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20247:00 amRNSTrading Statement
11th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSTrading Update and Directorate Change
7th Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Oct 20235:21 pmRNSTransaction in Own Shares
12th Oct 20235:22 pmRNSTransaction in Own Shares
11th Oct 20235:52 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.